Deamidation: Asparagine and glutamine residues undergo deamidation, creating acidic variants that alter stability and pharmacokinetics
Patients treated with Aurlumyn alone saw a 0% risk of amputation compared with 60% of those who did not receive the new treatment
Our team, guided by the expert insights of Brenda Johnson, MATS, PA-C, strongly encourages a comprehensive approach to your health
Youll receive: A personalized treatment protocol Detailed post-application care instructions Regular monitoring and progress checks Access to bundled treatment options, such as combining with physical therapy or regenerative services Is Peptide Therapy Right for You
Defaulting to D64.9 for all postoperative anemia cases is a specificity error that draws medical necessity scrutiny
This is of particular concern when non-medical practitioner administers this treatment or done in a non-sterile facility